Joe Tippens Fenbendazole Protocol 222 mg: Essential Guide
Joe Tippens’ fenbendazole protocol of 222 mg gained popularity after he disclosed his personal case of small cell lung cancer. The fenbendazole protocol and his related supplement routine received considerable following in the online cancer communities and throughout social media.
The Joe Tippens’ fenbendazole protocol of 222 mg must be considered carefully. His protocol was developed from an individual case report, anecdotal evidence, and documentation; it does not have validity as a cancer-treatment guideline. Additionally, Joe Tippens was undergoing standard-of-care cancer treatment at the time of his case report. Therefore, the protocol should not be considered a causal event in the case report.
How the Joe Tippens Fenbendazole Protocol 222 mg Started
According to published accounts, fenbendazole was one addition to his multisupplement regimen that included vitamin E, curcumin with piperine, and CBD oil. Scans and reported regression of his tumors gained a great deal of interest, both online and off.
This was named the Joe Tippens fenbendazole protocol 222 mg and shared as an example of successful cancer treatment, but it lacks evidence.
Original Joe Tippens Protocol: 222 mg Schedule
The Joe Tippens fenbendazole protocol 222 mg is normally explained as a three-day on/four-day off weekly schedule, with the other supplements reported as daily usage.
Original Protocol (Classic Version)
| Component | Commonly Reported Amount | Schedule |
| Fenbendazole | 222 mg | 3 consecutive days, then 4 days off; repeat weekly |
| Vitamin E | 400–800 mg | Daily; tocotrienols are commonly specified |
| Curcumin | 600 mg | Daily, commonly with meals |
| CBD oil | 25 mg | Daily |
These amounts describe the protocol as reported by the source and online forums. They are not standardized recommendations for human cancer treatment.
Why the 222 mg Figure Is So Frequently Mentioned
Why the 222 mg Figure Is So Frequently MentionedThe Joe Tippens fenbendazole protocol 222 mg stands out because the 222 mg amount became closely linked to the original story. Over time, online discussions produced additional schedules, making it important to distinguish the original description from later adaptations.
The source indicates that fenbendazole is a fat-soluble variant and that the online forms of the protocol often emphasize taking fenbendazole with a meal that includes fat. This should not be interpreted as a medically correct means to ameliorate cancer.
Later Variations of the Protocol
As interest grew, the Joe Tippens fenbendazole protocol 222 mg was modified by different online communities. In these variants, a schedule of continuous daily use replaced the schedule of intermittent use. These variants also included proprietary combinations of supplements.
Commonly Reported Later Variation
| Component | Commonly Reported Amount | Notes |
| Fenbendazole | 222 mg daily | Continuous use in some later versions |
| Onco Adjunct Pathway 1 | 2–4 mL twice daily | Weight-dependent proprietary blend |
| Onco Adjunct Pathway 2 | 3 capsules twice daily | Described in some protocol discussions |
| Onco Adjunct Pathway 3 | 1–2 capsules with meals | Used in some lower-sugar approaches |
| Onco Adjunct Pathway 4 | 2 capsules twice daily | Continuous in the cited version |
These variations were not formally validated and should not be confused with the original Joe Tippens fenbendazole protocol 222 mg.
Maintenance Versions Discussed Online
In some of the online sources, there are descriptions of maintenance regimens after an initial period. One of the reported versions is using the 222 mg dose three times per week with four days off.
Another described use of the 222 mg dose on a 10 weeks on / 10 weeks off regimen. In these descriptions, curcumin and CBD were reported to be used daily.
There are no published cancer guidelines which describe a medically sound maintenance regimen for the Joe Tippens fenbendazole protocol 222 mg. Therefore, these variations, which are described on the Internet, should be considered unstandardized opposed to legitimate treatment regimens.
What Does Research Say About Fenbendazole?
The Joe Tippens fenbendazole protocol 222 mg has gained interest due to some of the laboratory studies.
The effects of fenbendazole as related to microtubules, cell cycle, and glucose transport have been the subjects of several laboratory studies. For example, in 2018, it was shown to affect glucose metabolism in lung cancer cell lines. The fact that these studies are preclinical means they don’t show anything related to the treatment of cancer in humans.
The source states that a complete Tippens combination as a cancer treatment has not been verified by controlled human trials.
Safety Concerns to Consider
Since fenbendazole is a veterinary drug that has not been approved by the FDA for human use for cancer treatment, safety concerns are paramount for the Joe Tippens fenbendazole 222 mg protocol.
Reported concerns include gastrointestinal problems, fatigue, headache, and issues with an injured liver. The source shows an interaction with vitamin E, curcumin, CBD, and cancer medication.
Fenbendazole or supplements being given to a patient for cancer treatment without the oncology team being informed can make identifying the medications and side effects difficult.
Can It Be Used With Chemotherapy?
In regards to the Joe Tippens Fenbendazole Protocol 222 mg, some individuals have discussed this in the presence of chemotherapy. Laboratory studies have theorized the use of fenbendazole in concert with some chemotherapy drugs. Cell and animal models provide no basis for safety or efficacy in humans.
A 2026 ASCO review of real-world data at MD Anderson found 182 patients who self-reported Fenbendazole use among 297,223 patients reviewed, highlighting a 0.06% use case. The authors noted that the data captured substantial variation in dosing frequency and that there was no currently valid recorded use case.
In their June 2026 clinical policy, ASCO stated that fenbendazole should not be used as a cancer drug or as a supplement to standard cancer care outside the bounds of clinical research.
Final Thoughts
The Joe Tippens fenbendazole protocol 222 mg is popular because of Joe Tippens and his personal story. Online viral attention increased the interest in this protocol. The original protocol consists of three days of 222 mg fenbendazole, combined with vitamin E, curcumin, and CBD Oil, followed by four days off.
Later variants of the protocol have increasingly diverged from the original protocol, and there is still no accepted standard protocol. Current recommendations for oncology practice do not support the use of fenbendazole for the treatment of cancer.
People researching the Joe Tippens fenbendazole protocol 222 mg should consider online schedules as types of information rather than formal medical advice, and it is recommended to discuss this usage with the oncologist, especially during conventional cancer treatment.
References
- Sanare Lab – Joe Tippens Protocol
- ASCO – Fenbendazole and Cancer
- ASCO – Patterns of Fenbendazole Use